Clinical Features and Outcomes of Twin Pregnancies with Antiphospholipid Antibodies Positivity: A Retrospective Study

References

• Knight JS, Branch DW, Ortel TL. Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management. BMJ. 2023;380:e069717. doi:10.1136/bmj-2021-069717
   PubMedGoogle Scholar
• Dabit JY, Valenzuela-Almada MO, Vallejo-Ramos S, Duarte-García A. Epidemiology of antiphospholipid syndrome in the general population. Curr Rheumatol Rep. 2022;23(12):85. doi:10.1007/s11926-021-01038-2
   PubMed Web of Science ®Google Scholar
• Duarte-García A, Pham MM, Crowson CS, et al. The epidemiology of antiphospholipid syndrome: a population-based study. Arthritis Rheumatol. 2019;71(9):1545–1552. doi:10.1002/art.40901
   PubMed Web of Science ®Google Scholar
• Sisó-Almirall A, Kostov B, Martínez-Carbonell E, et al. The prevalence of 78 autoimmune diseases in Catalonia (MASCAT-PADRIS Big Data Project). Autoimmunity Rev. 2020;19(2):102448. doi:10.1016/j.autrev.2019.102448
   PubMed Web of Science ®Google Scholar
• Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306.
   PubMed Web of Science ®Google Scholar
• Gómez-Puerta JA, Cervera R. Diagnosis and classification of the antiphospholipid syndrome. J Autoimmun. 2014;48–49:20–25. doi:10.1016/j.jaut.2014.01.006
   PubMed Web of Science ®Google Scholar
• Taraborelli M, Reggia R, Dall’Ara F, et al. Longterm outcome of patients with primary antiphospholipid syndrome: a retrospective multicenter study. J Rheumatol. 2017;44(8):1165–1172. doi:10.3899/jrheum.161364
   PubMed Web of Science ®Google Scholar
• Högdén A, Antovic A, Berg E, Bremme K, Chaireti R. Obstetric outcomes in patients with primary thrombotic and obstetric antiphospholipid syndrome and its relation to the antiphospholipid antibody profile. Lupus. 2019;28(7):868–877. doi:10.1177/0961203319852155
   PubMed Web of Science ®Google Scholar
• Grygiel-Górniak B, Mazurkiewicz Ł. Positive antiphospholipid antibodies: observation or treatment? J Thromb Thrombolysis. 2023;56(2):301–314.
   PubMed Web of Science ®Google Scholar
• Andreoli L, Chighizola CB, Banzato A, Pons-Estel GJ, Ramire de Jesus G, Erkan D. Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. Arthritis Care Res. 2013;65(11):1869–1873. doi:10.1002/acr.22066
   Web of Science ®Google Scholar
• Fredi M, Andreoli L, Aggogeri E, et al. Risk factors for adverse maternal and fetal outcomes in women with confirmed aPL Positivity: results from a multicenter study of 283 pregnancies. Front Immunol. 2018;9:864. doi:10.3389/fimmu.2018.00864
   PubMed Web of Science ®Google Scholar
• Sammaritano LR, Bermas BL, Chakravarty EE, et al. 2020 American College of Rheumatology Guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Rheumatol. 2020;72(4):529–556. doi:10.1002/art.41191
   PubMed Web of Science ®Google Scholar
• Tektonidou MG, Andreoli L, Limper M, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheumatic Dis. 2019;78(10):1296–1304. doi:10.1136/annrheumdis-2019-215213
   PubMed Web of Science ®Google Scholar
• Monden C, Pison G, Smits J. Twin Peaks: more twinning in humans than ever before. Hum Reprod. 2021;36(6):1666–1673. doi:10.1093/humrep/deab029
   PubMed Web of Science ®Google Scholar
• Chen P, Li M, Mu Y, et al. Temporal trends and adverse perinatal outcomes of twin pregnancies at differing gestational ages: an observational study from China between 2012–2020. BMC Pregnancy Childbirth. 2022;22(1):467. doi:10.1186/s12884-022-04766-0
   PubMed Web of Science ®Google Scholar
• Santana DS, Silveira C, Costa ML, et al. Perinatal outcomes in twin pregnancies complicated by maternal morbidity: evidence from the WHO Multicountry Survey on Maternal and Newborn Health. BMC Pregnancy Childbirth. 2018;18(1):449. doi:10.1186/s12884-018-2082-9
   PubMedGoogle Scholar
• Madar H, Goffinet F, Seco A, Rozenberg P, Dupont C, Deneux-Tharaux C. Severe acute maternal morbidity in twin compared with singleton pregnancies. Obstetrics Gynecol. 2019;133(6):1141–1150. doi:10.1097/AOG.0000000000003261
   PubMed Web of Science ®Google Scholar
• Weitzner O, Barrett J, Murphy KE, et al. National and international guidelines on the management of twin pregnancies: a comparative review. Am J Obstet Gyneco. 2023;229(6):577–598. doi:10.1016/j.ajog.2023.05.022
   PubMed Web of Science ®Google Scholar
• Li H, Lyu M, Zhao R, et al. The maternal-neonatal outcomes of twin pregnancies with preeclampsia and their association with assisted reproductive technology: a retrospective study. Diagnostics. 2022;12(6):1334. doi:10.3390/diagnostics12061334
   Web of Science ®Google Scholar
• Wang Y, Wu N, Shen H. A review of research progress of pregnancy with twins with preeclampsia. Risk Manag Healthc Policy. 2021;14:1999–2010. doi:10.2147/RMHP.S304040
   PubMed Web of Science ®Google Scholar
• Greco E, Calanducci M, Nicolaides KH, Barry EVH, Huda MSB, Iliodromiti S. Gestational diabetes mellitus and adverse maternal and perinatal outcomes in twin and singleton pregnancies: a systematic review and meta-analysis. Am J Obstet Gynecol. 2024;230(2):213–225. doi:10.1016/j.ajog.2023.08.011
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. National Institute for health and care excellence: guidelines. In: Twin and Triplet Pregnancy. London: National Institute for Health and Care Excellence (NICE) Copyright © NICE 2019; 2019.
   Google Scholar
• Jin J, Xu X, Hou L, et al. Thrombocytopenia in the first trimester predicts adverse pregnancy outcomes in obstetric antiphospholipid syndrome. Front Immunol. 2022;13:971005. doi:10.3389/fimmu.2022.971005
   PubMed Web of Science ®Google Scholar
• Yang J, Liang M. Risk factors for pregnancy morbidity in women with antiphospholipid syndrome. J Reprod Immunol. 2021;145:103315. doi:10.1016/j.jri.2021.103315
   PubMed Web of Science ®Google Scholar
• Walter IJ, Klein Haneveld MJ, Lely AT, Bloemenkamp KWM, Limper M, Kooiman J. Pregnancy outcome predictors in antiphospholipid syndrome: a systematic review and meta-analysis. Autoimmunity Rev. 2021;20(10):102901. doi:10.1016/j.autrev.2021.102901
   PubMed Web of Science ®Google Scholar
• Erton ZB, Sevim E, de Jesús GR, et al. Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (‘Registry’). Lupus Sci Med. 2022;9(1):e000633. doi:10.1136/lupus-2021-000633
   PubMed Web of Science ®Google Scholar
• Li X, Deng X, Duan H, et al. Clinical features associated with pregnancy outcomes in women with positive antiphospholipid antibodies and previous adverse pregnancy outcomes: a real-world prospective study. Clin Rheumatol. 2021;40(1):193–204. doi:10.1007/s10067-020-05203-3
   PubMed Web of Science ®Google Scholar
• Duan H, Li X, Liu C, Ge Y, Deng X. Risk factors for pregnancy failure in patients with antiphospholipid antibody positivity and prior pregnancy losses: a retrospective study. J Reprod Immunol. 2020;141:103171. doi:10.1016/j.jri.2020.103171
   PubMed Web of Science ®Google Scholar
• Spinillo A, Bellingeri C, De Maggio I, et al. The impact of various entities of antiphospholipid antibodies positivity on adverse pregnancy outcome. An epidemiological perspective. J Reprod Immunol. 2021;145:103304. doi:10.1016/j.jri.2021.103304
   PubMed Web of Science ®Google Scholar
• Saccone G, Berghella V, Maruotti GM, et al. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study. Am J Obstet Gynecol. 2017;216(5):525.e521–525.e512.
   Web of Science ®Google Scholar
• Xu J, Chen D, Duan X, Li L, Tang Y, Peng B. The association between antiphospholipid antibodies and late fetal loss: a systematic review and meta-analysis. Acta obstetricia et gynecologica Scandinavica. 2019;98(12):1523–1533. doi:10.1111/aogs.13665
   PubMed Web of Science ®Google Scholar
• Gebhart J, Posch F, Koder S, et al. High risk of adverse pregnancy outcomes in women with a persistent lupus anticoagulant. Blood Adv. 2019;3(5):769–776. doi:10.1182/bloodadvances.2018026948
   PubMed Web of Science ®Google Scholar
• Latino JO, Udry S, Wingeyer SP, Romero DF, Micone P, de Larrañaga G. What is the best time to assess the antiphospholipid antibodies (aPL) profile to better predict the obstetric outcome in antiphospholipid syndrome (APS) patients? Immunol Res. 2018;66(5):577–583. doi:10.1007/s12026-018-9024-5
   PubMed Web of Science ®Google Scholar
• Holmes VA, Wallace JM. Haemostasis in normal pregnancy: a balancing act? Biochem Soc Trans. 2005;33(Pt 2):428–432.
   PubMedGoogle Scholar
• Liu L, Yang HS, Xu Z, et al. Explore the impact of abnormal coagulation test results on pregnancy complications and perinatal outcomes by establishing the trimester-specific reference intervals of singleton and twin pregnancies. Int j Clin Chem. 2023;541:117265. doi:10.1016/j.cca.2023.117265
   Google Scholar
• Ren K, Wei Y, Qiao R, Shi H, Gong X, Zhao Y. Changes in coagulation during twin pregnancies. Clin App Thrombosis/Hemostasis. 2020;26:1076029620983898. doi:10.1177/1076029620983898
   Web of Science ®Google Scholar